Please provide your email address to receive an email when new articles are posted on . A sirolimus-eluting balloon was noninferior to drug-eluting stents in treating de novo coronary lesions. The ...
In the treatment of larger narrowed blood vessels, drug-coated balloon catheters have been shown to deliver lasting and effective outcomes. Their minimally invasive nature makes them a viable ...
European Journal of Vascular and Endovascular Surgery Publishes Results Showing Comparable Safety and Efficacy of SurVeil™ DCB Despite IN.PACT™ Admiral™ DCB having 75% Higher Paclitaxel Dose. EDEN ...
Please provide your email address to receive an email when new articles are posted on . A paclitaxel-coated balloon bested conventional angioplasty in treating coronary in-stent restenosis. The coated ...
SAN FRANCISCO — A sirolimus-eluting balloon was found to be noninferior to conventional stenting in separate trials of patients undergoing percutaneous coronary interventions (PCIs), suggesting these ...
Jerry Bailey was awake while a medical team at OhioHealth Mansfield Hospital reopened one of his previously stented arteries using a new heart procedure. "It's working," the 73-year-old said a few ...
Data from first coronary DCB study in U.S. meet 12-month primary endpoint, demonstrate low adverse event rates with AGENT DCB While coronary stenting is commonly used to restore blood flow to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results